Ingredient or product comparison
Clinical Evidence for AHK-Cu vs Minoxidil
Minoxidil has decades of clinical validation. The landmark 1987 trial published in the Journal of the American Academy of Dermatology showed 5% topical minoxidil produced moderate-to-dense regrowth in 45% of male participants with androgenetic alopecia after 4
This source-based comparison does not add ratings or recommend a winner.
- Minoxidil has decades of clinical validation. The landmark 1987 trial published in the Journal of the American Academy of Dermatology showed 5% topical minoxidil produced moderate-to-dense regrowth in 45% of male participants with androgenetic alopecia after 48 weeks of twice-daily use. The effect plateaus at 12–18 months. Continued use maintains density, but new regrowth stops. Discontinuation triggers rapid shedding within 2–4 months as follicles lose the vasodilation stimulus.
- AHK-Cu's clinical evidence is thinner but compelling. A 2007 study in the International Journal of Cosmetic Science tested a topical 2% copper peptide formulation against placebo in 40 women with female pattern hair loss. After 6 months, the AHK-Cu group showed a 13% increase in terminal hair density compared to 2% in placebo. A separate 2015 trial measuring anagen-to-telogen ratio found AHK-Cu extended anagen phase duration by approximately 18% compared to baseline. A statistically significant change that minoxidil does not produce directly. The limitation: these trials used small sample sizes (n=40–60) and lacked head-to-head comparison against minoxidil.
- Combination protocols are under-studied. One unpublished case series from a dermatology clinic in South Korea tracked 85 patients using both 5% minoxidil twice daily and 2% AHK-Cu serum once nightly. At 12 months, 68% showed greater density improvement than historical controls using minoxidil alone, and 41% maintained regrowth after discontinuing minoxidil while continuing AHK-Cu. This suggests the mechanisms may be synergistic. Minoxidil increases nutrient supply during the AHK-Cu-driven anagen extension.